03:25 PM EDT, 07/18/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows:

We up our 12-month target by $6 to $23, valuing IVZ shares at 12x our 2025 EPS view of $1.90 and 10.7x our 2026 EPS estimate of $2.15. IVZ shares are up today on news it plans to convert its flagship ETF, the Invesco QQQ Trust (QQQ 561 *****), from its current unit investment trust structure to an open-ended fund structure. QQQ, with $352.7B of assets under management (as of June 30, 2025) and a 0.20% fee structure, currently generates over $700M in fee revenues. Most of these fees accrue to the UIT's trustee and index provider, not IVZ. Under the proposal, subject to an October shareholder vote, Invesco Capital Management (a unit of IVZ) would be appointed as the investment adviser to QQQ and the management fee would drop to 0.18%. Because this is subject to a vote, we have not changed our EPS views, but this conversion could potentially drive over $600M in gross fee revenues to IVZ. We previously saw IVZ as an undervalued franchise. This news provides the shares (now yielding 5%) with another catalyst.